Folger Hill Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Folger Hill Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-67,882	Closed	-$6.8M	–	316
2017 Q2	$6.8M	Buy	67,882 +42,882	+172%	+$4.61M	0.61%	66
2017 Q1	$3.02M	Buy	+25,000	New	+$3.07M	0.24%	121
2016 Q3	–	Sell	-146,152	Closed	-$14M	–	296
2016 Q2	$13.4M	Sell	146,152 -6,465	-4%	-$544K	1.04%	26
2016 Q1	$11M	Sell	152,617 -23,416	-13%	-$1.28M	0.62%	35
2015 Q4	$12.2M	Buy	+176,033	New	+$14.3M	0.74%	39

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Folger Hill Asset Management's GWPH Position: Q3 2017 in Review

Folger Hill Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2017, closing a stake of 67,882 shares — an estimated $6.8M sold.

Folger Hill Asset Management first reported a position in GWPH in Q4 2015 and held it in 5 quarters. The position peaked at $13.4M in Q2 2016. 181 funds tracked by Wall St. Rank hold GWPH as of Q3 2017.

Folger Hill Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2017 after selling out during the quarter.
Folger Hill Asset Management sold 67,882 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2017, an estimated $6.8M.
Folger Hill Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2015 and held it in 5 quarters.
Folger Hill Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $13.4M in Q2 2016.
181 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2017.

Based on Folger Hill Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.